Ainos (OTCMKTS:AIMD) Shares Up 3%

Ainos, Inc. (OTCMKTS:AIMD) shares shot up 3% on Wednesday . The company traded as high as $0.87 and last traded at $0.85. 80,297 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 1,301,984 shares. The stock had previously closed at $0.82.

Ainos Stock Down 3.9 %

The company has a market cap of $5.29 million, a price-to-earnings ratio of -0.33 and a beta of 1.39. The business has a fifty day moving average of $0.97 and a two-hundred day moving average of $1.23. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08.

Ainos (OTCMKTS:AIMD) last announced its earnings results on Monday, May 13th. The company reported ($0.57) earnings per share (EPS) for the quarter. The company had revenue of $0.02 million during the quarter. Ainos had a negative net margin of 515.80% and a negative return on equity of 44.32%.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.